Ceribell EV/FCF

Mitä Ceribell tekee? Ceribell Inc is a health care company based in Sunnyvale, California, with 327 employees. The company went public on October 11, 2024, with the ticker CBLL and ISIN US15678C1027. Ceribell focuses on developing medical technology for the diagnosis and management of serious neurological conditions. The company has created a point-of-care electroencephalography (EEG) platform called the Ceribell System. This system combines portable hardware with AI-powered algorithms to enable rapid diagnosis and continuous monitoring of patients in acute care settings. The Ceribell System allows for early detection of seizures and supports precise patient care through real-time EEG interpretation. The company's Clarity AI algorithm provides bedside alerts and continuous monitoring for status epilepticus. Ceribell also offers an EEG Portal for managing patient data. The company's technology aims to improve hospital efficiencies by addressing unmet needs in neurological care. Ceribell operates in the health care sector with a focus on neurological conditions. The company's website is https://ceribell.com/. Ceribell on yksi Eurpooliin suosituimmista yhtiöistä.